Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

626
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
626
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

753
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
753
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.0K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.0K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

11
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
11

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Catalyst-Free Selective Reduction of Nitrogen Dioxide to Nitric Oxide.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

NETosis associates with human TB lung tissue destruction and disease pathogenesis.

EMBO molecular medicine·2026
Same author

Predicting trajectories of illness using RNA velocity of whole blood.

Nature communications·2026
Same author

Activation of N<sub>2</sub>O, CO<sub>2</sub>, and CO at a sterically protected phosphorus center.

Dalton transactions (Cambridge, England : 2003)·2026
Same author

Context-specific roles for IL-17 in tuberculosis.

PLoS pathogens·2026
Same author

Bridging the Gap: Optimizing OPAT Transitions to Skilled Nursing Facilities.

Open forum infectious diseases·2026
Same journal

Brief digital narrative intervention for adolescent depression, anxiety, and insomnia during academic stress: a cluster randomized controlled trial.

BMC medicine·2026
Same journal

Effect of Vitamin C on bleeding and pain after kidney biopsy: a randomized controlled trial.

BMC medicine·2026
Same journal

Impact of gestational diabetes on future diabetic retinopathy and microvascular complications: a nationwide cohort study.

BMC medicine·2026
Same journal

Convergence of schizophrenia risk genes on CALN1 disrupts human forebrain development and drives core psychotic behaviors including hallucination-like perception.

BMC medicine·2026
Same journal

Efficacy of leflunomide in active Takayasu arteritis: a randomized double-blind placebo-controlled trial subtitle: Takayasu arteritis clinical trial in China (TACTIC).

BMC medicine·2026
Same journal

Refined AI-ASPECTS with modified atlas and lesion-load thresholds: advancing acute ischemic stroke imaging and prognostic prediction.

BMC medicine·2026
See all related articles

Related Experiment Video

Updated: Mar 23, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

13.3K

Diagnostic 'omics' for active tuberculosis.

Carolin T Haas1, Jennifer K Roe1, Gabriele Pollara1

  • 1Division of Infection and Immunity, University College London, Cruciform Building, Gower Street, London, WC1E 6BT, UK.

BMC Medicine
|March 24, 2016
PubMed
Summary
This summary is machine-generated.

Developing rapid diagnostic tests for active tuberculosis (TB) is crucial. This study explores transcriptomics, proteomics, and metabolomics to create next-generation TB diagnostics for faster, more accurate patient assessment.

Keywords:
-OmicsDiagnosticsDiseaseTuberculosis

More Related Videos

Amplicon Sequencing using the Long-Read Sequencing Technologies
08:57

Amplicon Sequencing using the Long-Read Sequencing Technologies

Published on: August 29, 2025

626
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.7K

Related Experiment Videos

Last Updated: Mar 23, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

13.3K
Amplicon Sequencing using the Long-Read Sequencing Technologies
08:57

Amplicon Sequencing using the Long-Read Sequencing Technologies

Published on: August 29, 2025

626
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.7K

Area of Science:

  • Infectious Diseases
  • Biomarker Discovery
  • Diagnostic Development

Background:

  • Current active tuberculosis (TB) diagnosis relies on slow microbiological tests or assays that cannot differentiate active from latent infection.
  • Challenges in sample collection and the limitations of existing diagnostic methods necessitate the development of rapid, sensitive tests.
  • There is a critical need for diagnostics that can assess TB exposure, distinguish TB from other diseases, and detect subclinical TB in HIV-1 patients.

Purpose of the Study:

  • To evaluate peripheral blood transcriptomics, proteomics, and metabolomics for next-generation active TB diagnostics.
  • To review and analyze existing studies on discriminating active TB using omics approaches.
  • To identify limitations and barriers to clinical adoption of novel TB diagnostic biomarkers.

Main Methods:

  • Review of published studies on peripheral blood transcriptomics, proteomics, and metabolomics for active TB detection.
  • Analysis of studies comparing active TB patients with healthy controls, latent TB, and other diseases.
  • Identification of limitations and challenges in current diagnostic biomarker research for TB.

Main Results:

  • Existing diagnostic methods for active TB are often slow and lack sensitivity or specificity.
  • Omics approaches (transcriptomics, proteomics, metabolomics) show promise for developing rapid TB diagnostics.
  • Numerous studies have explored these omics approaches, but clinical adoption faces significant barriers.

Conclusions:

  • Peripheral blood omics hold significant potential for developing rapid and sensitive active TB diagnostics.
  • Further research is needed to overcome limitations in current studies and facilitate clinical implementation.
  • A framework is proposed to guide the discovery and development of next-generation active TB diagnostic biomarkers.